US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?

Summary Allogeneic islet transplantation is a standard of care treatment for patients with labile type 1 diabetes in many countries around the world, including Japan, the United Kingdom, Australia, much of continental Europe, and parts of Canada. The United States is now endorsing islet cell treatme...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transplant international 2021-07, Vol.34 (7), p.1182-1186
Hauptverfasser:	Piemonti, Lorenzo, Andres, Axel, Casey, John, Koning, Eelco, Engelse, Marten, Hilbrands, Robert, Johnson, Paul, Keymeulen, Bart, Kerr‐Conte, Julie, Korsgren, Olle, Lehmann, Roger, Lundgren, Torbjörn, Maffi, Paola, Pattou, Francois, Saudek, Frantisek, Shaw, James, Scholz, Hanne, White, Steve, Berney, Thierry
Format:	Artikel
Sprache:	eng
Schlagworte:	Commercialization Diabetes Diabetes mellitus Diabetes mellitus (insulin dependent) European medicines agency food and drug administration Human tissues Islet cells Life Sciences Pancreatic islet transplantation regulatory authorities Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!